INS and Hypoglycemia: Results of RCTs suggest that it is possible to switch from a basal bolus insulin regimen to a combination of BI plus either a GLP-1 RA or a SGLT2i, with same or better glycemic control, less injections, less insulin doses, less hypoglycemia and increased satisfaction of therapy [8].